YARAL Pharma delivers high-quality authorized and complex generics across multiple therapeutic areas with reliable supply and exceptional service — reimagining generics by “doing things differently” for patients and pharmacies.
Company Background
YARAL Pharma Inc., launched in 2022, is the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland. Built on IBSA’s commitment to “drugs in the best form,” YARAL delivers high-quality, affordable, authorized and complex generic medicines across key therapeutic areas — including endocrinology and pain and inflammation — while ensuring continuity of supply and patient-focused innovation.
Created to expand IBSA’s presence in the U.S. market, YARAL combines global manufacturing excellence with a customer-first approach. Since its launch, the company has quickly become one of IBSA’s top-performing subsidiaries, recognized for its consistent product quality, reliability of supply, and responsive service.
YARAL’s portfolio focuses on high-value, differentiated generics — including topical patches and softgel technologies — that meet real needs in today’s pharmacy practice. Guided by quality, reliability, and innovation, YARAL is helping pharmacists provide patients with trusted treatment options across multiple therapeutic areas.
Product Overview
YARAL Pharma delivers high-quality generic medicines designed with enhanced drug delivery technologies to improve the patient experience.
Testimonial
“Pharmacy Podcast Network values the perspective YARAL Pharma brings as a generics company that does things differently, offering innovative solutions and insights that resonate with our listeners. Including pharmaceutical manufacturers in our conversations who are genuinely committed to the success of pharmacists has proven to be impactful, and we’re excited to continue working with YARAL Pharma to further support the pharmacy community.”
— Todd Eury, CEO and Founder of Pharmacy Podcast Network
Features & Options
YARAL Pharma is redefining what it means to be a generics company in today’s competitive healthcare landscape.
Optimized Formulations
Limited inactive ingredients to support tolerability.
Advanced Delivery Systems
Innovative options — including topical systems and softgel capsules — designed for real-world needs.
Reliable Supply & Service
Exceeding performance targets with 95% on time, shipping to customers backed by exceptional customer care.
Expanded Access
Quality, affordable treatments across endocrinology, pain and inflammation, and more.
Trusted Partnerships
Committed to creating long-term value with distributors, pharmacies, and healthcare providers.
Enhancing Drug Delivery Technology
YARAL applies innovative technologies to generic medications to improve the patient experience.
Softgel Capsules
Use IBSA’s unique PEARLtec™ technology to transform semi-liquid solutions into easy-to-administer forms, reducing excipients and supporting tolerability.
Topical Patches
Employ hydrogel or drug-in-adhesive systems for controlled release and less frequent dosing.
Trade Shows/Meetings Attended
American Pharmacists Association (APhA)
National Community Pharmacists Association (NCPA)
American Society of Health-System Pharmacists (ASHP)
Contact Information
Customer Service: For more information, email info@yaralpharma.com or call (866) 218-9009.
Ordering Information: yaralCS@eversana.com
